Investegate |SDIC Power Holdings Announcements | SDIC Power Holdings: Notice of the 2022 third EGM
Investegate announcements from SDIC Power Holdings, Notice of the 2022 third EGM
Source: investegate.co.uk
Page 7 - Authorized Persons News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Authorized Persons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Authorized Persons Today - Breaking & Trending Today
Aelis Farma, a biopharmaceutical company developing a new generation of drugs for brain diseases, announces the success of its initial public offering and raises approximately €25 million on Euronext Paris
16.02.2022 - Regulatory News: Aelis Farma (Paris: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases (the 'Company'), announces today the successful completion of its initial public offering on ...
Source: wallstreet-online.de
Aelis Farma, a biopharmaceutical company developing a new generation of drugs for brain diseases, announces the success of its initial public offering and raises approximately €25 million on Euronext Paris
Capital increase of approximately €25 million, i.e. 100% of the initial objective, despite high market volatility Size of the transaction which may be increased to approximately €25.55 million
Source: finanznachrichten.de
Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Launches Its Initial Public Offering on the Regulated Market of Euronext Paris
02.02.2022 - Regulatory News: Not to be distributed, directly or indirectly, in the United States of America, Canada, Australia, Japan or South Africa. Aelis Farma, a clinical-stage biopharmaceutical company specializing in the development of treatments for ...
Source: wallstreet-online.de
Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Launches Its Initial Public Offering on the Regulated Market of Euronext Paris
Capital increase of €25 million, which may be increased to a maximum of approximately €33 million in the event the Extension Clause and the Over-Allotment Option are fully exercised Irrevocable
Source: finanznachrichten.de